Christopher C. Fikry, M.D., has been appointed executive vice president of PPD Laboratories.

Dr. Fikry joins the company from Quest Diagnostics, where he most recently served as vice president and general manager for oncology and companion diagnostics. Previously he served as vice president of clinical trials, where he led the company’s central laboratory, biomarker and companion diagnostic services.
 
“Chris will apply his extensive industry experience and leadership skills to guide the continued growth of our laboratory business by ensuring exceptional quality and service for our clients,” said William Sharbaugh, chief operating officer for PPD. “With pharmaceutical and biotech companies’ needs in clear focus, Chris and our talented lab teams will continue to bring our clients world-class scientific expertise, state-of-the-art technology and a commitment to innovation in helping develop new life-changing therapies.”